Furthermore, it has been proven that the up-regulation of IL-7 and Tnf-α drives the up-regulation of Gfi1, a transcriptional factor with repressor activity, which in turn reduces the activity of Runx2 in the MSCs and OBs of MM patients [73]. The gene discussed is GFI1; the disease is Miyoshi myopathy.